About HealthBanks

Providing the Best Cell Banking Experience in the Industry with Premium Technology and World Class Service

Automated Stem Cell Banking

Best-in-Class Automated Stem Cell Banking and Storage Technology

Immune Cell Banking

First-in-Class Immune Cell Banking Service for the Future

California Based Company

California-Based Company with Global Vision and Network

ImmuneCyte Logo

HealthBanks, formally known as Pacificord, was originally founded in 2001. Through a series of merger and consolidations, the HealthBanks Group and its affiliates have become a world’s premium cell banking network. HealthBanks headquarters in Irvine, CA. The core businesses of the group focus on cell banking, cell processing and cell therapies, servicing clients in 40 countries around the world.

  • In 2008, HealthBanks became the first company to offer families cord tissue storage in the world.
  • In 2020, HealthBanks became the first company in US to offer GMP Compliant Immune Cell Banking Service.
Our subsidiary ImmuneCyte is a leading drug development & research company focused on immunotherapies

Accreditations

HealthBanks is FDA registered and licensed by the State of California Department of Health which requires us to comply with the current AABB standards for cell therapy, California Health and Safety Code, California Business and Professional Code and California Code of Regulations. HealthBanks also has a license in California for blood, tissue, clinical testing, and biologics along with a New York license for tissue banking. HealthBanks is also a standing member of the Irvine Chamber of Commerce and participates in API and CAP proficiency testing.

lgbtq flag

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.

*Price Match is based on the same technology and service scope.